Wilkins-Haug L E, Tworetzky W, Benson C B, Marshall A C, Jennings R W, Lock J E
Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Boston, MA 02115, USA.
Ultrasound Obstet Gynecol. 2006 Jul;28(1):47-52. doi: 10.1002/uog.2732.
We have reported previously that valve dilation enhances growth of cardiac structures and may prevent hypoplastic left heart syndrome (HLHS) in fetuses with critical aortic stenosis. We aimed to investigate maternal/fetal factors which may affect the technical success of fetal valvuloplasty, and to describe perinatal complications of the procedure.
This was a descriptive series of 22 fetuses diagnosed with critical aortic stenosis developing into HLHS which underwent intervention by valvuloplasty. Initially this was attempted using a percutaneous approach; reassessment after our first five attempts, only one of which was successful, led to the introduction of the option of laparotomy. Technical success was defined as balloon inflation across the aortic annulus and a broader jet through the aortic valve as assessed by Doppler. Data collected included body mass index, demographic variables, ultrasound findings and postprocedure interventions.
Technical success increased significantly if maternal laparotomy was an option (83.3% vs. 20.0%, P = 0.017). Laparotomy was performed in 66.6% (12/18) of cases. There was a learning curve that showed an increase in success rate and decrease in need for laparotomy over the 3-year study period. Neither the need for laparotomy nor the chances of technical success were predictable by gestational age, body mass index or placental location. Tocolysis was limited to perioperative prophylaxis; one woman experienced wound infection and fluid overload. Postoperatively, three fetuses died and two delivered prematurely, 2 and 7 weeks after intervention.
Fetal aortic valvuloplasty can be performed with technical success, with low fetal loss rate and few maternal complications. While the need for laparotomy cannot be predicted, having it available as an option improves the technical success rate.
我们之前报道过瓣膜扩张可促进心脏结构生长,并可能预防患有严重主动脉瓣狭窄的胎儿发生左心发育不全综合征(HLHS)。我们旨在研究可能影响胎儿瓣膜成形术技术成功率的母体/胎儿因素,并描述该手术的围产期并发症。
这是一项描述性系列研究,纳入了22例诊断为严重主动脉瓣狭窄并发展为HLHS的胎儿,这些胎儿接受了瓣膜成形术干预。最初尝试采用经皮途径;在最初五次尝试后进行重新评估,其中只有一次成功,这导致引入了剖腹手术选项。技术成功定义为通过多普勒评估,球囊在主动脉瓣环处充盈且通过主动脉瓣的血流束增宽。收集的数据包括体重指数、人口统计学变量、超声检查结果和术后干预措施。
如果有母体剖腹手术选项,技术成功率显著提高(83.3%对20.0%,P = 0.017)。66.6%(12/18)的病例进行了剖腹手术。在3年的研究期间存在学习曲线,显示成功率增加且剖腹手术需求减少。孕周、体重指数或胎盘位置均无法预测是否需要剖腹手术或技术成功的可能性。宫缩抑制剂仅限于围手术期预防;1名女性出现伤口感染和液体超负荷。术后,3例胎儿死亡,2例在干预后2周和7周早产。
胎儿主动脉瓣膜成形术可取得技术成功,胎儿丢失率低且母体并发症少。虽然无法预测是否需要剖腹手术,但将其作为一种选择可提高技术成功率。